微比恩 > 信息聚合 > RELX Starts China’s First Clinical Study on E-Cigarette Safety

RELX Starts China’s First Clinical Study on E-Cigarette Safety

2022-02-08 02:47:00来源: 钛媒体

BEIJING, February 7 (TMTPOST) — Chinese e-cigarette maker RELX’s clinical study on the safety of e-cigarettes has been registered successfully on ChiCTR (China Clinical Trial Registry).RELX’s research project is said to be the first clinical study to focus on the safety of e-cigarettes in China.The company also started a clinical study on e-cigarettes earlier in March 2021. The clinical study last y

关注公众号
标签: AR on